Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence

Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence

Alcohol Use Disorder (AUD) is a chronic and relapsing condition characterized by harmful alcohol intake and behavioral-cognitive changes. AUD is the most common cause of liver disease in the Western world. Alcohol abstinence is the cornerstone of therapy in alcoholic patients affected with liver dis...

Full description

Bibliographic Details
Main Authors: Carolina Mosoni, Tommaso Dionisi, Gabriele Angelo Vassallo, Antonio Mirijello, Claudia Tarli, Mariangela Antonelli, Luisa Sestito, Maria Margherita Rando, Alberto Tosoni, Salvatore De Cosmo, Antonio Gasbarrini, Giovanni Addolorato
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Psychiatry
Subjects:
alcohol use disorder
baclofen
alcoholic liver disease
liver cirrhosis
GABA-B receptor
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00474/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2018.00474/full

Similar Items